Following primary infection, human cytomegalovirus (HCMV) establishes lifelong latency
and periodically reactivates without causing symptoms in healthy individuals. In the absence …

Human cytomegalovirus (HCMV) is a herpesvirus that infects~ 60% of adults in developed
countries and more than 90% in developing countries. Usually, it is controlled by a vigorous …

The human cytomegalovirus (HCMV) can cause lifelong infection with episodes of
endogenous reactivation. Intrauterine fetal infection and infection of immunocompromised …

Human cytomegalovirus (HCMV) can establish both nonproductive (latent) and productive
(lytic) infections. Many of the proteins expressed during these phases of infection could be …

While the host immune response following primary human cytomegalovirus (HCMV)
infection is generally effective at stopping virus replication and dissemination, virus is never …

Infections with human cytomegalovirus (HCMV) are a major cause of morbidity and mortality
in humans with acquired or developmental deficits in innate and adaptive immunity. In the …

Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that still causes severe
morbidity and mortality in immunocompromised individuals. During its evolution, the virus …

Human cytomegalovirus (HCMV) infection is largely asymptomatic in the immunocompetent
host, but remains a major cause of morbidity in immunosuppressed individuals. Using the …

Human cytomegalovirus (HCMV) is a recognized cause of disease in the fetus, the allograft
recipient and AIDS patients. More recently, it has been recognized as a pathogen for those …

Cytomegalovirus, of the Herpesviridae family, has evolved alongside humans for thousands
of years with an intricate balance of latency, immune evasion, and transmission. While …